About Genomi-K
Genomi-K is a company based in Monterrey (Mexico) founded in 2010 by Xavier Toussaint. It operates as a B2B, and D2C. Genomi-K offers products and services including Támi-k, Áudi-k, and Cárdi-k. Genomi-K operates in a competitive market with competitors including Cordlife, Natera, SYNLAB, Progenity and Sequenom, among others.
- Headquarter Monterrey, Mexico
- Founders Xavier Toussaint
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Genomi-K
Genomi-K offers a comprehensive portfolio of products and services, including Támi-k, Áudi-k, and Cárdi-k. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Program for early detection of metabolic diseases in newborns.
Service for identifying hearing issues in infants promptly.
Tool for detecting congenital heart defects early in babies.
Funding Insights of Genomi-K
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Genomi-K
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Genomi-K
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Genomi-K Comparisons
Competitors of Genomi-K
Genomi-K operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cordlife, Natera, SYNLAB, Progenity and Sequenom, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cordlife is engaged in cord blood banking and diagnostics.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of medical diagnosis and clinical laboratory analysis services
|
|
| domain | founded_year | HQ Location |
Non-invasive prenatal genomic testing is provided for genetic disorders.
|
|
| domain | founded_year | HQ Location |
Noninvasive prenatal testing using cell-free fetal nucleic acids is offered.
|
|
| domain | founded_year | HQ Location |
Molecular diagnostics for prenatal genetic testing are specialized in.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Genomi-K
When was Genomi-K founded?
Genomi-K was founded in 2010.
Where is Genomi-K located?
Genomi-K is headquartered in Monterrey, Mexico. It is registered at Monterrey, Nuevo Leon, Mexico.
Who is the current CEO of Genomi-K?
Xavier Toussaint is the current CEO of Genomi-K. They have also founded this company.
What does Genomi-K do?
Genomi-k specializes in comprehensive programs for neonatal screening, focusing on metabolic, auditory, and cardiac conditions to enable early detection and intervention. These services are delivered through partnerships with hospitals, such as Hospitales Puerta de Hierro, and target newborns to prevent diseases. The company operates by integrating these programs into maternity packages, serving healthcare providers and parents with a focus on preventive care, though exact locations are not fully specified.
Who are the top competitors of Genomi-K?
What products or services does Genomi-K offer?
Genomi-K offers Támi-k, Áudi-k, and Cárdi-k.